Grail names new CEO as Bob Ragusa retires

Jared Whitlock / endpoints - Grail on Thursday announced that its CEO, Bob Ragusa, will retire and is handing the reins to its current president Josh Ofman. The cancer screening company said the move was the culmination of long-term succession ...

AI Summary: Grail announced a leadership transition as long‑time chief executive Bob Ragusa retires and hands operational control to current president Josh Ofman. The move marks a new chapter for the cancer‑screening company as stakeholders watch for strategic shifts and commentary about the company’s unusual corporate journey and future direction.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 2 months

FDA clears blood test to guide breast cancer therapy choices / 22 days

Liquid biopsy may speed childhood Burkitt lymphoma diagnosis in Africa / 2 months

Cancer Grand Challenges awards five teams bold funding for cancer research / 2 months

Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 11 days

Grail’s Galleri blood test misses UK study goal; investor jitters / 3 months

Bristol Myers and Hengrui strike up to $15.2B global oncology pact / 16 days